Medical devices, healthcare technology and the business of care
PMA approval · P180031

Neuroform Atlas Stent System

Stryker Neurovascular · Decision date May 16, 2019

MEDTECHLEDGER EXPLANATIONP180031

What did the FDA approve?

The FDA approved the Neuroform Atlas Stent System for use with neurovascular embolization coils in the anterior circulation of the neurovasculature. The approval covers endovascular treatment of patients 18 years or older with saccular wide-necked intracranial aneurysms, defined as neck width of 4 mm or greater or a dome-to-neck ratio below 2.

The device is limited to aneurysms arising from a parent vessel with a diameter of at least 2.0 mm and no more than 4.5 mm. The decision date is May 16, 2019, and the applicant is Stryker Neurovascular. The source statement describes the approved scope but does not provide independent proof of safety or clinical effectiveness.

FDA approval order statement

Approved for use with neurovascular embolization coils in the anterior circulation of the neurovasculature for the endovascular treatment of patients greater or equal to 18 years of age with saccular wide-necked (neck width greater or equal to 4 mm or a dome-to-neck ratio of < 2) intracranial aneurysms arising from a parent vessel with a diameter of greater or equal to 2.0 mm and less than or equal to 4.5 mm.
Regulatory pathway
Original PMA
Clinical specialty
Neurology
Decision date
May 16, 2019

FDA source record · MedtechLedger’s explanation describes the recorded change.

Regulatory record facts

Identifier
P180031
Regulatory pathway
Premarket approval application
Product code
QCA
Decision code
APPR
Decision date
May 16, 2019
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Intracranial coil-assist stent.

Product code
QCA
FDA device class
3

The approval statement above describes the scope recorded for this original decision. Later supplements may change the device or its indications.

FDA decision timeline

  1. P180031 received

    Application receipt date recorded by FDA.

  2. P180031 · FDA decision

    APPR

  3. P180031/S012 · Related supplement

    Neuroform Atlas Stent System

Timeline entries are records held by MedtechLedger for P180031. View FDA’s full supplement list.

Related devices and submissions

Same PMA: P180031

Product / regulatory recordCompanyPathwayDecision dateSource
Stryker NeurovascularPMA supplementOct 24, 2026FDA

Explore the linked device profile

Other records with product code QCA

Product / regulatory recordCompanyPathwayDecision dateSource
Microvention, Inc.PMA supplementSep 16, 2026FDA
Microvention, Inc.PMA approvalMay 30, 2018FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

An original PMA is a premarket approval application. The recorded approval scope is described in FDA’s order and supporting documents.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Stryker Neurovascular

Headquarters
Not reported
Brand website
stryker.com
FDA applicant address
47900 Bayside Pkwy., Fremont, CA, 94538

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records